Jefferies Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $9.42M | Buy |
70,155
+16,993
| +32% | +$2.44M | 0.08% | 199 |
|
|
2022
Q2 | $8.14M | Buy |
53,162
+6,786
| +15% | +$1.04M | 0.07% | 237 |
|
|
2022
Q1 | $7.52M | Buy |
46,376
+20,186
| +77% | +$2.93M | 0.05% | 302 |
|
|
2021
Q4 | $3.55M | Buy |
26,190
+6,504
| +33% | +$768K | 0.02% | 590 |
|
|
2021
Q3 | $2.12M | Buy |
19,686
+17,717
| +900% | +$2.02M | 0.02% | 742 |
|
|
2021
Q2 | $222K | Buy |
+1,969
| New | +$222K | ﹤0.01% | 1386 |
|
|
2021
Q1 | – | Sell |
-1,661
| Closed | -$178K | – | 1576 |
|
|
2020
Q4 | $178K | Sell |
1,661
-877
| -35% | -$84.3K | ﹤0.01% | 1395 |
|
|
2020
Q3 | $222K | Sell |
2,538
-14,085
| -85% | -$1.33M | ﹤0.01% | 1161 |
|
|
2020
Q2 | $1.63K | Sell |
16,623
-113,091
| -87% | -$9.96M | 0.02% | 631 |
|
|
2020
Q1 | $9.88M | Buy |
129,714
+90,196
| +228% | +$7.68M | 0.11% | 160 |
|
|
2019
Q4 | $3.5M | Buy |
39,518
+24,382
| +161% | +$2.02M | 0.03% | 711 |
|
|
2019
Q3 | $1.15M | Sell |
15,136
-47,501
| -76% | -$3.26M | 0.01% | 1432 |
|
|
2019
Q2 | $4.55M | Buy |
62,637
+22,922
| +58% | +$1.8M | 0.03% | 516 |
|
|
2019
Q1 | $3.2M | Buy |
39,715
+29,155
| +276% | +$2.39M | 0.03% | 647 |
|
|
2018
Q4 | $974K | Sell |
10,560
-62,993
| -86% | -$5.54M | 0.01% | 1168 |
|
|
2018
Q3 | $6.96M | Sell |
73,553
-121,678
| -62% | -$11.5M | 0.05% | 406 |
|
|
2018
Q2 | $18.1M | Buy |
195,231
+48,564
| +33% | +$4.74M | 0.1% | 125 |
|
|
2018
Q1 | $13.9M | Buy |
146,667
+88,878
| +154% | +$9.76M | 0.07% | 179 |
|
|
2017
Q4 | $5.59M | Sell |
57,789
-30,451
| -35% | -$2.87M | 0.03% | 522 |
|
|
2017
Q3 | $7.84M | Buy |
88,240
+31,684
| +56% | +$2.41M | 0.05% | 365 |
|
|
2017
Q2 | $4.1M | Sell |
56,556
-108,372
| -66% | -$7.29M | 0.03% | 621 |
|
|
2017
Q1 | $10.7M | Buy |
164,928
+159,003
| +2,684% | +$10M | 0.08% | 245 |
|
|
2016
Q4 | $371K | Sell |
5,925
-127,202
| -96% | -$7.76M | ﹤0.01% | 1692 |
|
|
2016
Q3 | $8.4M | Sell |
133,127
-33,730
| -20% | -$2.18M | 0.04% | 370 |
|
|
2016
Q2 | $10.3M | Buy |
166,857
+162,917
| +4,135% | +$9.93M | 0.05% | 282 |
|
|
2016
Q1 | $225K | Sell |
3,940
-4,719
| -54% | -$263K | ﹤0.01% | 1801 |
|
|
2015
Q4 | $513K | Sell |
8,659
-171,220
| -95% | -$9.86M | ﹤0.01% | 1525 |
|
|
2015
Q3 | $9.79M | Buy |
179,879
+178,924
| +18,735% | +$11.6M | 0.06% | 271 |
|
|
2015
Q2 | $64K | Sell |
955
-162,291
| -99% | -$10.6M | ﹤0.01% | 2353 |
|
|
2015
Q1 | $9.56M | Buy |
+163,246
| New | +$9.86M | 0.05% | 248 |
|
|
2014
Q4 | – | Sell |
-106,738
| Closed | -$6.73M | – | 1886 |
|
|
2014
Q3 | $6.17M | Buy |
106,738
+74,629
| +232% | +$4.14M | 0.04% | 362 |
|
|
2014
Q2 | $1.81M | Buy |
32,109
+18,858
| +142% | +$989K | 0.02% | 672 |
|
|
2014
Q1 | $680K | Buy |
13,251
+10,413
| +367% | +$526K | 0.01% | 1109 |
|
|
2013
Q4 | $150K | Sell |
2,838
-117,709
| -98% | -$5.79M | ﹤0.01% | 1656 |
|
|
2013
Q3 | $5.39M | Buy |
120,547
+55,264
| +85% | +$2.45M | 0.05% | 305 |
|
|
2013
Q2 | $2.7M | Buy |
+65,283
| New | +$2.86M | 0.03% | 395 |
|
Other funds holding ABBV
Jefferies Group's ABBV Position: Q3 2022 in Review
Jefferies Group increased its AbbVie (ABBV) stake by 32% in Q3 2022, buying an estimated $2.44M and bringing the position to 70,155 shares worth $9.42M. The position accounts for 0.08% of the portfolio, ranked #199.
Jefferies Group first reported a position in ABBV in Q2 2013 and has held it in 36 quarters since. The position peaked at $18.1M in Q2 2018. 2,968 funds tracked by Wall St. Rank hold ABBV as of Q3 2022.
- Jefferies Group held 70,155 shares of AbbVie worth $9.42M as of Q3 2022.
- Jefferies Group bought 16,993 AbbVie shares in Q3 2022, an estimated $2.44M.
- AbbVie made up 0.08% of Jefferies Group's portfolio in Q3 2022, its #199 holding.
- Jefferies Group first reported a position in AbbVie in Q2 2013 and has held it in 36 quarters since.
- Jefferies Group's AbbVie position peaked at $18.1M in Q2 2018.
- 2,968 funds tracked by Wall St. Rank held AbbVie as of Q3 2022.
Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.